Pyxis Oncology, Inc.
PYXS
Last
$2.03
Day
+2.0%
1y
-48.0%
5y
-84.9%
52w
-64.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0222d
EMA 21
2.60
EMA 50
2.81
EMA 200
2.48
20d high
-43.4%
5y high
-89.5%
5y range
6th
Positions held
Your positionsPYXS isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-16
Hold
avoid
Signal
Strong Sell
Target
$2.39
Stop
$1.66
Stop distance
18.2%
Target vs last
+17.7%
Fundamentals
| Market cap | $237.72M | Enterprise value | $150.82M | Trailing P/E | — | Forward P/E | -1.80 |
| PEG | — | Price / book | 11.06 | Beta | 1.38 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 78.4% | Operating margin | -8.1% |
| Profit margin | 0.0% | ROE | -1.8% | ROA | -63.0% | Debt / equity | 1.56 |
| Current ratio | 1.34 | Free cash flow | -$23.19M | Analyst recommendation | none | Mean target | $8.67 |
| 52w high | $5.55 | 52w low | $1.03 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $11.0M | $0.0M | $2.8M | — |
| Op margin | — | — | -165.7% | — | -700.4% | — |
| Net income | -$25.3M | -$23.3M | -$18.1M | -$22.0M | -$18.4M | — |
| Gross margin | — | — | 78.4% | — | 100.0% | — |
| Gross profit | — | — | $8.7M | $0.0M | $2.8M | $0.0M |
| Operating income | -$26.0M | -$24.4M | -$18.3M | -$23.5M | -$19.8M | — |
- Gross margin 78.4% (was 100% prior quarter).
- Operating margin expanded to -165.7%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $13.9M | $16.1M | $0.0M | $0.0M | — |
| Op margin | -609.2% | -424.2% | — | — | — |
| Net income | -$79.6M | -$77.3M | -$73.8M | -$121M | — |
| Gross margin | 82.8% | 97.1% | — | — | — |
| Gross profit | $11.5M | $15.7M | $0.0M | — | — |
| Operating income | -$84.4M | -$68.5M | -$82.2M | -$123M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsPYXS · daily-40.7% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin